Skip to content

Drug interactions

Nateglinide + Vadadustat

Severity: Minor

Nateglinide and Vadadustat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vadadustat is a substrate of renal organic anion transporters OAT1 and OAT3, and drugs that inhibit these transporters can raise vadadustat exposure. Higher exposure may cause an excessive or overly rapid rise in hemoglobin and more adverse effects. Nateglinide is listed as a possible inhibitor, but the clinical significance is uncertain.

What this interaction means in plain words

Nateglinide and Vadadustat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Nateglinide belongs to Endocrine; Vadadustat belongs to Endocrine.

Evidence level: Low

Why it happens

Possible inhibition of OAT1/OAT3-mediated renal transport of vadadustat, increasing its AUC; this is largely predicted rather than demonstrated.

What to do

Monitor hemoglobin regularly and adjust the vadadustat dose per labeling if the rise is too rapid. Watch for adverse effects such as hypertension and thrombotic events.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nateglinide and Vadadustat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nateglinide with Vadadustat?

MediHelp rates the interaction as minor. Nateglinide and Vadadustat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Vadadustat is a substrate of renal organic anion transporters OAT1 and OAT3, and drugs that inhibit these transporters can raise vadadustat exposure. Higher exposure may cause an excessive or overly rapid rise in hemoglobin and more adverse effects. Nateglinide is listed as a possible inhibitor, but the clinical significance is uncertain.

How serious is the interaction between Nateglinide and Vadadustat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor hemoglobin regularly and adjust the vadadustat dose per labeling if the rise is too rapid. Watch for adverse effects such as hypertension and thrombotic events.

What other medicines interact with Nateglinide?

MediHelp also lists interactions of Nateglinide with, for example, Albiglutide, Alogliptin-metformin, Alogliptin-pioglitazone. The full list is on the Nateglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in